Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Based on breakthrough discovery made in collaboration with Brown University researchers
April 7, 2020
By: Contract Pharma
Contract Pharma Staff
Drugs for the treatment of COVID-19 are in desperate need world-wide. A rapid drug discovery platform that can help identify drugs for the treatment of COVID-19 is essential for identifying viable treatments. Based on a joint research effort, Applied Biology and Brown University researchers concluded that the androgen receptor may be implicated in COVID-19 mortality risk. Therefore, human type II pneumocytes androgen sensitivity should be tested as a potential treatment marker. The team led by Carlos Wambier, director of cosmetic research at the department of dermatology of the Alpert Medical School of Brown University and Andy Goren, chief medical officer at Applied Biology and medical advisor to the department of dermatology of the Alpert Medical School of Brown University along with a team of collaborators from other institutions submitted their discovery to publication in the medical journal Dermatologic Therapy (DOI: 10.1111/dth.13365). “We believe that androgens are required for the expression of the serine protease TMPRSS2,” said Dr. Wambier. “This proteolytic priming of the spikes of the coronavirus is the first step required for binding to the ACE2 receptor in cells. Male hormones might also affect ACE2 receptor expression in lung cells. To the best of our knowledge these are required for the novel coronavirus to infect humans.” According to Dr. Goren, said, “Testing androgen sensitivity along with ACE2 and TMPRSS2 expression provides a rapid method to assess the effectiveness of drug candidates in inhibiting the cellular entry of COVID-19.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !